The ApoB test: what your standard cholesterol panel might be missing

By Dr. Nicki Byrne, Medical Director, Optispan

Most of us are familiar with cholesterol testing. We know about LDL, often called “bad cholesterol,” and HDL, or “good cholesterol.” But there’s another marker that I think deserves more attention when we’re evaluating cardiovascular risk: apolipoprotein B, or ApoB.

Key points

• Each of these particles carries one ApoB protein, so measuring ApoB gives us a good estimate of how many potentially plaque-forming particles are circulating in the blood.
• You can have an LDL cholesterol level that looks reassuring while still having more plaque-forming particles than we’d like.
• The test itself is simple. It’s a standard blood draw that can be performed alongside your other routine labs.
• Reducing saturated fat is one of the most effective dietary strategies for lowering ApoB.

What is ApoB?

ApoB is a protein found on the surface of the cholesterol-carrying particles that contribute to plaque buildup in our arteries. Each of these particles carries one ApoB protein, so measuring ApoB gives us a good estimate of how many potentially plaque-forming particles are circulating in the blood.

Why does that matter? Because when it comes to cardiovascular disease, the amount of cholesterol in your blood isn’t the whole story. The number of particles carrying that cholesterol matters too.

Why your cholesterol can look normal when your risk isn’t

A standard cholesterol panel measures LDL cholesterol, or LDL-C. This tells us how much cholesterol is being carried by LDL particles in your bloodstream, but not how many particles are carrying it.

Think of it this way: two people can have exactly the same LDL cholesterol level, but one may have fewer particles carrying more cholesterol each, while the other has many more particles carrying less cholesterol each. Those particles can enter the walls of our arteries, where they can become trapped and contribute to plaque formation. Over time, that plaque can lead to heart attacks and strokes. The more particles circulating in your blood, the greater the opportunity for plaque to develop.

For many people, LDL-C and ApoB tell a similar story. But they don’t always agree. We call this discordance, and it’s particularly common in people with elevated triglycerides, insulin resistance, type 2 diabetes, or excess abdominal fat.

This is one reason I don’t like relying on a standard cholesterol panel alone when trying to understand someone’s cardiovascular health. You can have an LDL cholesterol level that looks reassuring while still having more plaque-forming particles than we’d like.

Who should get an ApoB test?

The American College of Cardiology and American Heart Association released updated cholesterol management guidelines in 2026 that specifically recognize the value of ApoB testing in certain patients.

The guidelines highlight ApoB as particularly useful for people with elevated triglycerides, diabetes, or known cardiovascular disease, especially when their LDL cholesterol is already at goal but there may be additional risk that we’re missing.

I would strongly consider ApoB testing if you:

• Have elevated triglycerides, insulin resistance, prediabetes, or type 2 diabetes.
• Have a family history of premature cardiovascular disease.
• Have known cardiovascular disease or are already taking cholesterol-lowering medication.
• Have other cardiovascular risk factors, such as chronic kidney disease or excess abdominal fat.
• Want a more complete understanding of your cardiovascular risk, particularly if your standard cholesterol results don’t seem to match your overall health picture.

Not everyone needs ApoB measured routinely. But in the right patient, it can provide information that changes how we approach prevention.

How is ApoB tested?

The test itself is simple. It’s a standard blood draw that can be performed alongside your other routine labs.

What does your ApoB number mean?

ApoB is measured in milligrams per deciliter (mg/dL). In general, lower ApoB levels mean fewer circulating particles capable of contributing to plaque formation.

But there isn’t one ideal ApoB level for everyone.

Someone who is young, metabolically healthy, and has no significant cardiovascular risk factors may have a different treatment goal than someone with diabetes, a strong family history of heart disease, or evidence of plaque in their arteries.

The 2026 American guidelines continue to use LDL cholesterol and non-HDL cholesterol as the primary treatment targets, while recognizing that ApoB can help identify additional risk and guide treatment decisions.

For example, someone may have successfully lowered their LDL cholesterol with medication but still have an elevated ApoB. That finding may prompt us to consider whether additional cholesterol lowering would be beneficial.

At Optispan, we’re interested in understanding an individual’s risk over decades, not just estimating their likelihood of having a heart attack in the next ten years.

That means looking at ApoB in the context of blood pressure, blood sugar, family history, genetics, and, when appropriate, cardiovascular imaging.

The goal isn’t simply to get a lab value into the normal range. It’s to reduce the risk of developing cardiovascular disease in the first place.

How to lower ApoB

The good news is that many of the same interventions we recommend for cardiovascular health can also help lower ApoB.

Nutrition

Reducing saturated fat is one of the most effective dietary strategies for lowering ApoB. This generally means limiting foods such as butter, processed meats and fatty cuts of meat while emphasizing unsaturated fats from foods like olive oil, nuts, seeds, and fish. Increasing soluble fiber through foods such as oats, beans, and lentils can also help.

Weight management and metabolic health

For people with excess body fat or insulin resistance, losing weight and improving metabolic health can help reduce the number of circulating atherogenic particles. The effect varies, but it’s another reason to address metabolic health rather than focusing on cholesterol alone.

Exercise, including Zone 2

Regular exercise is one of the most important things we can do for long-term cardiovascular health. Aerobic training, including Zone 2 exercise, improves insulin sensitivity, helps lower triglycerides, and supports cardiovascular fitness.

Exercise alone generally has a relatively modest effect on ApoB. However, its benefits extend far beyond cholesterol, including improvements in blood pressure, glucose regulation, and cardiovascular function. I view exercise as a foundational part of cardiovascular prevention, even when it doesn’t dramatically change someone’s cholesterol numbers.

Medication

Oftentimes lifestyle changes aren’t enough, particularly when genetics play a significant role or someone already has substantial cardiovascular risk.

Statins remain a first-line treatment for lowering LDL cholesterol and ApoB. Other medications, including ezetimibe, PCSK9 inhibitors, and bempedoic acid, may also be appropriate depending on someone’s risk and response to treatment.

One of the important messages from the 2026 guidelines is that earlier treatment can reduce the cumulative exposure of our arteries to these particles over a lifetime. In other words, preventing plaque from developing is generally preferable to waiting until cardiovascular disease is already present.

One more test I recommend: Lp(a)

If we’re talking about cardiovascular risk beyond a standard cholesterol panel, there’s another marker worth knowing: lipoprotein(a), or Lp(a).

Lp(a) is a genetically determined type of cholesterol-carrying particle that contains ApoB. Elevated levels are associated with increased risk of cardiovascular disease and calcific aortic valve disease.

Unlike LDL cholesterol, Lp(a) is largely determined by your genetics and generally isn’t significantly improved by diet or exercise.

The 2026 guidelines recommend that every adult have Lp(a) measured at least once in their lifetime. In general, levels below 75 nmol/L are considered lower risk, while cardiovascular risk increases as Lp(a) rises. Levels of 125 nmol/L or higher (approximately 50 mg/dL, although the conversion varies by assay) are considered a risk-enhancing factor for cardiovascular disease.

If your Lp(a) is elevated, it doesn’t mean you’re destined to develop heart disease. But it does mean we should be more proactive about managing the risk factors we can control, particularly LDL cholesterol, ApoB, blood pressure, and metabolic health.

For most people, Lp(a) only needs to be measured once, whereas ApoB can be followed over time to evaluate the response to lifestyle changes and treatment.

How we use ApoB at Optispan

At Optispan, we take a comprehensive approach to cardiovascular prevention. ApoB is one of the markers we use to better understand a patient’s cardiovascular risk, alongside traditional cholesterol testing, Lp(a), metabolic markers, and other clinical information.

We don’t interpret these results in isolation. We consider them alongside your family history, blood pressure, body composition, cardiovascular fitness, and, when appropriate, imaging that can identify early evidence of atherosclerosis.

For patients in our longitudinal programs, repeat testing allows us to evaluate whether lifestyle interventions and medications are producing the changes we want to see.

The goal is to identify risk early, make informed decisions, and track whether those decisions are improving your long-term health.

The bottom line

A standard cholesterol panel remains an important tool for evaluating cardiovascular health, but it doesn’t always tell us the whole story.

ApoB helps us better understand the number of particles that can contribute to plaque buildup in our arteries. For some people, that additional information can meaningfully change how we approach prevention.

And that’s really the point of preventive medicine: understanding risk before it becomes disease, while we still have the opportunity to change the trajectory.

Interested in learning more about your cardiovascular health? Book a free 15-minute consultation with the Optispan care team.

Frequently asked questions about ApoB

Is ApoB better than LDL cholesterol?

Both are useful, but they measure different things. LDL-C measures the amount of cholesterol carried by LDL particles, while ApoB reflects the number of particles capable of contributing to plaque formation. ApoB can be particularly valuable when the two measurements don’t agree. Current guidelines continue to use LDL-C as a primary treatment target, with ApoB providing additional information in selected patients.

Do I need to fast for an ApoB test?

Usually not. ApoB can generally be measured without fasting, although your physician may request fasting if other tests are being performed at the same time.

Can I lower ApoB without medication?

Yes. Dietary changes, particularly reducing saturated fat and increasing soluble fiber, can meaningfully lower ApoB. Weight loss may also help, especially in people with insulin resistance. However, genetics play a substantial role in cholesterol metabolism, and some people will need medication to achieve an appropriate level of risk reduction.

How often should ApoB be checked?

It depends on why we’re measuring it. If you’re starting a new medication or making significant lifestyle changes, repeating testing after approximately 6–12 weeks can help assess your response. Once levels are stable, testing can generally be less frequent and tailored to your individual risk and treatment plan.

This article is intended for general educational purposes and does not constitute individualized medical advice. Discuss testing and treatment decisions with your physician.